Loading...
REMSleep Holdings, Inc.
RMSL•PNK
Healthcare
Medical - Devices
$0.007
$-0.00(-7.12%)
REMSleep Holdings, Inc. (RMSL) Financial Performance & Income Statement Overview
Review REMSleep Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-42.48%
↓ 42.48%
Operating Income Growth
55.21%
↑ 55.21%
Net Income Growth
39.36%
↑ 39.36%
Operating Cash Flow Growth
13.68%
↑ 13.68%
Operating Margin
-1350.29%
↓ 1350.29%
Gross Margin
-44.27%
↓ 44.27%
Net Profit Margin
-1536.67%
↓ 1536.67%
ROE
-203.18%
↓ 203.18%
ROIC
-318.76%
↓ 318.76%
REMSleep Holdings, Inc. (RMSL) Income Statement & Financial Overview
Review REMSleep Holdings, Inc.'s (RMSL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | -$5550.00 | $37260.00 | $27594.00 | $57881.00 |
| Cost of Revenue | -$6504.00 | $58560.00 | $5940.00 | $41151.00 |
| Gross Profit | $954.00 | -$21300.00 | $21654.00 | $16730.00 |
| Gross Profit Ratio | -$0.17 | -$0.57 | $0.78 | $0.29 |
| R&D Expenses | -$194983.00 | $40775.00 | $132020.00 | $22188.00 |
| SG&A Expenses | $186845.00 | $132040.00 | $186499.00 | $118757.00 |
| Operating Expenses | $179307.00 | $172815.00 | $318519.00 | $140945.00 |
| Total Costs & Expenses | $172803.00 | $231375.00 | $324459.00 | $182096.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $17843.00 | $64392.00 | $32932.00 | $27979.00 |
| Depreciation & Amortization | -$793.55B | $9804.00 | $26084.00 | $27561.00 |
| EBITDA | -$793.55B | -$203710.00 | -$166583.00 | -$197040.00 |
| EBITDA Ratio | $142.98M | -$5.47 | -$6.04 | -$3.40 |
| Operating Income | -$178348.00 | -$194115.00 | -$296865.00 | -$124220.00 |
| Operating Income Ratio | $32.13 | -$5.21 | -$10.76 | -$2.15 |
| Other Income/Expenses (Net) | -$1078.00B | -$83794.00 | $71266.00 | -$128365.00 |
| Income Before Tax | -$1078.00B | -$277909.00 | -$225599.00 | -$252580.00 |
| Income Before Tax Ratio | $194.23M | -$7.46 | -$8.18 | -$4.36 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$321909.00 | -$277909.00 | -$225599.00 | -$252580.00 |
| Net Income Ratio | $58.002 | -$7.46 | -$8.18 | -$4.36 |
| EPS | -$730.07 | -$0.00 | -$0.00 | -$0.00 |
| Diluted EPS | -$730.07 | -$0.00 | -$0.00 | -$0.00 |
| Weighted Avg Shares Outstanding | $1.48B | $1.51B | $1.47B | $1.46B |
| Weighted Avg Shares Outstanding (Diluted) | $1.48B | $1.51B | $1.47B | $1.46B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan